助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   肝硬化 在 特种医学 分类中 的翻译结果: 查询用时:0.058秒
图标索引 在分类学科中查询
所有学科
特种医学
消化系统疾病
感染性疾病及传染病
临床医学
外科学
肿瘤学
中医学
中药学
基础医学
更多类别查询

图标索引 历史查询
 

肝硬化     
相关语句
  liver cirrhosis
    THE CLINICAL SIGNIFICANCE OF COMBINED DETERMINATION OF SERUM AFP AND CA19-9 IN THE DIFFERENTIAL DIAGNOSIS OF PRIMARY LIVER CANCER AND LIVER CIRRHOSIS
    AFP、CA19-9联检在原发性肝癌和肝硬化鉴别诊断中的临床意义
短句来源
    Objective To detect the clinical applicative value of multi-slice spiral CT portal venography in displaying portacaval collateral vessels in patients of liver cirrhosis with portal hypertension.
    目的探讨多排螺旋CT门静脉造影(CT portal venography,CTPV)显示肝硬化门脉高压侧支循环血管的临床应用价值。
短句来源
    The F protein was found in 89.2% patients with acute hepatitis, 85.4% hepatic carcinoma, 79.6% alcoholic hepatitis, and 64.5% liver cirrhosis.
    阳性检出率原发性肝癌85.4%、急性肝炎89.2%、酒精性肝炎79.6%、肝硬化64.5%。
短句来源
    CT Manifestations of Spontaneous Right Posterior Portal Vein -IVC Shunts inPatients with Liver Cirrhosis
    肝硬化自发性门脉右后支-下腔静脉交通的螺旋CT表现
短句来源
    Study of CT grading of liver cirrhosis
    肝硬化CT分级方法研究
短句来源
更多       
  cirrhosis
    Preliminary Evaluation of Portal-systemic Shunts in Hepatic Cirrhosis with  ̄(99m)Tc-MIBI Per-rectum Imaging
    ~(99m)Tc-MIBI直肠-门脉显像测定肝硬化门静脉分流的初步观察
短句来源
    CT Manifestations of Portal Venous System and Portal-Systemic Collateral Circulation in Posthepatitis Cirrhosis
    肝炎后肝硬化的门静脉系及门体侧支CT表现
短句来源
    THE CLINICAL SIGNIFICANCE OF COMBINED DETERMINATION OF SERUM AFP AND CA19-9 IN THE DIFFERENTIAL DIAGNOSIS OF PRIMARY LIVER CANCER AND LIVER CIRRHOSIS
    AFP、CA19-9联检在原发性肝癌和肝硬化鉴别诊断中的临床意义
短句来源
    Objective To detect the clinical applicative value of multi-slice spiral CT portal venography in displaying portacaval collateral vessels in patients of liver cirrhosis with portal hypertension.
    目的探讨多排螺旋CT门静脉造影(CT portal venography,CTPV)显示肝硬化门脉高压侧支循环血管的临床应用价值。
短句来源
    The F protein was found in 89.2% patients with acute hepatitis, 85.4% hepatic carcinoma, 79.6% alcoholic hepatitis, and 64.5% liver cirrhosis.
    阳性检出率原发性肝癌85.4%、急性肝炎89.2%、酒精性肝炎79.6%、肝硬化64.5%。
短句来源
更多       
  hepatic cirrhosis
    Preliminary Evaluation of Portal-systemic Shunts in Hepatic Cirrhosis with  ̄(99m)Tc-MIBI Per-rectum Imaging
    ~(99m)Tc-MIBI直肠-门脉显像测定肝硬化门静脉分流的初步观察
短句来源
    Influence of Hepatic Cirrhosis on Effect of Liver Enhancement of CT and the Study of Improvement
    肝硬化对肝脏CT增强效果的影响及改进措施
短句来源
    CT Predict and ROC Analyse the Risk of Upper GastrointestinalHemorrhage of Portal Hypertension Caused by Hepatic Cirrhosis
    CT预测肝硬化门静脉高压并发上消化道出血风险的ROC分析
短句来源
    Investigation to liver volume change of hepatic cirrhosis by multi-slice spiral CT
    多层螺旋CT对肝硬化患者肝脏体积变化的研究
短句来源
    2. The average peak enhancement of MTPV and HP in compensated hepatic cirrhosis groups were 187. 5 26Hu and 104. 2 17Hu, respectively.
    2.肝硬化代偿期患者门静脉主干的强化峰值平均为187.5±26Hu,峰值时间平均为50±8秒;
短句来源
更多       
  hepatocirrhosis
    Evaluation of the Degree of Hepatocirrhosis with Liver Cell Imaging by SPECT
    探讨SPECT肝细胞显像评价肝硬化程度
短句来源
    CT Perfusion Imaging of Hepatocirrhosis in Rats: An Experimental Study
    肝硬化大鼠肝脏CT灌注成像的实验性研究
短句来源
    To evaluate the clinical value of portal-systemic shunt by the study on apiece time H/L ratio imaging in hepatocirrhosis, administration of Tcm-MIBI per rectum was performed in 10 healthy subjects and 36 patients with 99 cirrhosis by calculating H/L ratio and SI within 7 periods in 15—240 min to analyze the degree of hepatocirrhosis as- sociated with portal-systemic shunt.
    通过心、肝时相显像对门脉性肝硬化门-体分流诊断的研究,验证门-体分流值的临床意义。 方法是对10例正常者及36例门脉性肝硬化患者采用Tcm-MIBI直肠给药,分别在15—240min内的7个不同时相获取99H/L比值及SI,以便对肝硬化所致的门-体分流及程度进行分析。
短句来源
    We have found that there is a marked difference between the H/L ratios of the control group and of the hepatocirrhosis group A, B, C ( t = 15.87, 11.76, 16.11, P < 0.001 ) , and there is a good cor- relation between H / L ratio and SI ( r = 0.926, P < 0.001 ) .
    结果显示正常组与肝硬化A、B、C组H/L比值有极显著性差异(t分别为15.87、11.76、16.11,P<0.001),SI与H/L比值有良好匹配性。 肝硬化Child-pugh分级之间均有显著性差异(P<0.001)。
短句来源
    Clinical value of spiral CT during arterial portography in the evaluating of the hepatocirrhosis and portal hypertension
    SCTAP评价肝硬化及门静脉高压的临床价值
短句来源
更多       

 

查询“肝硬化”译词为其他词的双语例句

 

查询“肝硬化”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  liver cirrhosis
Postoperative hepatic insulin-like growth factor-1 (IGF-1) production may be severely disturbed in patients with liver cirrhosis.
      
Patients with advanced liver cirrhosis frequently develop the hepatorenal syndrome, a condition characterized by renal failure, marked reduction in renal blood flow and overactivity of endogenous vasoactive systems.
      
Second, for differential diagnosis of renal failure in liver cirrhosis, an algorithm was developed and the criteria defining the presence of a HRS are given.
      
The study offered a strong evidence for discrimination of liver cirrhosis in PEM.
      
Regarding infusion therapy, we were mainly interested in whether an amino acid solution adapted to the metabolism in liver cirrhosis causes an accumulation of BCAA in muscle or modifies the intracellular content of glutamate and glutamine.
      
更多          
  cirrhosis
In treating hepatocellular carcinoma (HCC) patients with advanced cirrhosis, one of the most difficult problems is concomitant esophageal varices and hypersplenism.
      
The surgical treatment methods for cirrhosis patients complicated with portal hypertension are complicated.
      
From 1979 to 2005, 274 cirrhosis patients with portal hypertension who underwent the new treatment strategy were followed up to observe different clinical indexes, which were then compared with those of the traditional surgery treatment.
      
Postoperative hepatic insulin-like growth factor-1 (IGF-1) production may be severely disturbed in patients with liver cirrhosis.
      
Twenty-four patients with HCC with cirrhosis who underwent hepatectomy were randomly divided into two groups: a PN group (n = 12) and an rhGH + PN group (n = 12).
      
更多          
  hepatic cirrhosis
The search for biochemical predictors of the NAT2 phenotype to optimize prophylaxis and pharmacotherapy of hepatic cirrhosis
      
Of them, 84.4% were associated with hepatic cirrhosis.
      
These results indicated that activated C-erbB-2, N-ras and altered p53 genes may have a role in human HCC pathogenesis through promiting the development of HCC from hepatic cirrhosis and the progression of HCC.
      
Conclusion: iNOS and eNOS may play a role in malignant transformation f post-hepatic cirrhosis.
      
Secondary medical management in PBC should address the treatment of complications of chronic cholestasis, hepatic cirrhosis, and liver failure.
      
更多          
  hepatocirrhosis
In the 40th-60th days, granulomatous reactions and mild hepatocirrhosis were the main lesions.
      
In the 70th-80th days, hepatocirrhosis and bile duct proliferation were observed in the liver.
      
Viral hepatitis, hepatic fibrosis and hepatocirrhosis etc.
      
  其他


点击这里查询相关文摘
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关肝硬化的内容
在知识搜索中查有关肝硬化的内容
在数字搜索中查有关肝硬化的内容
在概念知识元中查有关肝硬化的内容
在学术趋势中查有关肝硬化的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社